releases: https://harris.house.gov/media/press-releases/harris-reacts-following-second-delay-insulinepipen-savings-rule

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url	title	date	year	month	party	chamber	state	member_name	bioguide_id	domain	scraper	source	date_source	text	has_text	collected_at	updated_at
https://harris.house.gov/media/press-releases/harris-reacts-following-second-delay-insulinepipen-savings-rule	Harris Reacts Following Second Delay of Insulin/EpiPen Savings Rule	2021-03-10	2021	2021-03	Republican	House	MD	Andy Harris	H001052	harris.house.gov	harris	https://harris.house.gov/media/press-releases	scraper	WASHINGTON, DC: Congressman Andy Harris, M.D., today reacted to the Biden Administration's second delay of a Trump era executive action which would lower the consumer cost of insulin and EpiPens in community health centers. The Administration is now planning to delay the cost-saving rule until July 20th, four months after their the previous delayed launch date of March 22nd, and a full six months after the initial implementation date the Trump Administration had established. Dr. Harris had previously criticized the initial delay by President Biden to keep costs high for some of our most vulnerable. Congressman Harris issued the following statement: "Once again, the Biden Administration has chosen to delay significant cost-saving policy measures which would make insulin and EpiPens much more easily affordable to those who utilize our community health centers for care. The policy in question was not political, yet this political delay will do nothing other than harm individuals relying on these medications and keep drug prices high." Maryland's First Congressional District is served by 5 community health centers, with over 100,000 patients and millions of dollars in leveraged federal funding each year.	1	2026-03-30T01:40:41Z	2026-04-06T19:33:37Z